Filing Details
- Accession Number:
- 0001104659-21-030721
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-02 16:06:45
- Reporting Period:
- 2021-03-02
- Accepted Time:
- 2021-03-02 16:06:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1835205 | Ibere Pharmaceuticals | IBERU | Blank Checks (6770) | 981564986 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1840123 | J. Louis Vollmer | C/O Ibere Pharmaceuticals 2005 Market Street, Suite 2030 Philadelphia PA 19103 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Units | Acquisiton | 2021-03-02 | 10,000 | $10.00 | 35,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Units were acquired in a directed unit program in connection with the Issuer's initial public offering.
Billionaire Hedge Funds
